GET THE APP

Journal of Leukemia

Journal of Leukemia
Open Access

ISSN: 2329-6917

Journal of Leukemia : Citations & Metrics Report

Articles published in Journal of Leukemia have been cited by esteemed scholars and scientists all around the world. Journal of Leukemia has got h-index 11, which means every article in Journal of Leukemia has got 11 average citations.

Following are the list of articles that have cited the articles published in Journal of Leukemia.

  2021 2020 2019 2018 2017 2016

Year wise published articles

62 23 11 8 22 23

Year wise citations received

54 59 64 98 109 74
Journal total citations count 618
Journal impact factor 2.11
Journal 5 years impact factor 3.71
Journal cite score 3.91
Journal h-index 11
Journal h-index since 2017 8
Important citations

Combination of the pi3k inhibitor idelalisib with the conventional cytostatics cytarabine and dexamethasone leads to changes in pathway activation that induce anti-proliferative efects in b lymphoblastic leukaemia cell lines

Molecular characterisation of interaction between nurse-like cells and chronic lymphocytic leukaemia cells

Asmaa m. zahran, sawsan m. moeen, ahmad f. thabet, amal rayan, mona hussein abdel-rahim, wael m. y. mohamed & helal f. hetta (2020) monocytic myeloid-derived suppressor cells in chronic lymphocytic leukemia patients: a single center experience, leukemia & lymphoma, 61:7, 1645-1652

Prosthetic rehabilitation of surgically treated case of squamous cell carcinoma of retromolar trigone: a case report.

Prosthetic rehabilitation of surgically treated case of squamous cell carcinoma of retromolar trigone: a case report.

Effect of deferiprone versus deferiprone with deferasirox in iron chelation therapy of thalassemia children

Comparative study of deferiprone versus deferiprone with deferasirox as iron chelation therapy in thalassemic children

Prosthetic rehabilitation of surgically treated case of squamous cell carcinoma of retromolar trigone: a case report

Prosthetic rehabilitation of surgically treated case of squamous cell carcinoma of retromolar trigone: a case report.

Symptom cluster and quality of life in children with leukemia receiving chemotherapy.

Dasatinib in first- and second-line therapy of chronic myeloid leukemia: efficacy, safety and quality of life

Dasatinib in the first and second line of therapy for chronic myeloid leukemia: efficacy, safety and quality of life of patients

Association of t315i mutation with resistance to tyrosine kinase inhibitor therapy in patients with cml attended the oncology-hematology center in al-najaf city of iraq

Comparison of sokal score and hasford score on response to imatinib mesylate therapy in chronic granulocytic leukemia patients at dr. saiful anwar malang

Re-defining prognosis of hematological malignancies by dynamic response assessment methods: lessons learnt in chronic myeloid leukemia, hodgkin lymphoma, diffuse large b cell lymphoma and multiple myeloma

Pattern of neurological complications of chronic myeloid leukaemia in ilorin, nigeria: a ten year review

Priapism in patients with chronic myeloid leukemia (cml): a systematic review

Priapism as a warning sign for chronic myeloid leukemia

Idiopathic aplastic anemia in children and adults: diagnosis, treatments, and management

Discovery of a highly potent and selective bruton’s tyrosine kinase inhibitor avoiding impairment of adcc effects for b-cell non-hodgkin lymphoma

Relevant Topics

Top